Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 1,541.9 | 1,092.7 | 742.6 | 595.4 |
| Revenue growth | 41.1% | 47.2% | 24.7% | |
| Cost of goods sold | 339.4 | 352.5 | 242.4 | 165.4 |
| Gross profit | 1,202.5 | 740.1 | 500.2 | 430.0 |
| Gross margin | 78.0% | 67.7% | 67.4% | 72.2% |
| Sales and marketing | 614.5 | 683.7 | 450.1 | 461.8 |
| Research and development | 387.5 | 560.7 | 305.6 | 285.5 |
| General and administrative | 611.5 | 669.4 | 320.9 | 306.2 |
| EBIT | -411.0 | -1,173.7 | -576.4 | -623.4 |
| EBIT margin | -26.7% | -107.4% | -77.6% | -104.7% |
| Pre-tax income | -488.5 | -1,179.0 | -567.3 | -570.9 |
| Income taxes | 31.9 | -12.6 | 12.4 | 9.1 |
| Tax rate | | 1.1% | | |
| Net income | -520.4 | -1,166.4 | -579.6 | -598.1 |
| Net margin | -33.7% | -106.7% | -78.1% | -100.5% |
| |
| Diluted EPS | ($0.27) | ($1.19) | ($1.00) | ($1.10) |
| Shares outstanding (diluted) | 1,923.6 | 979.3 | 577.0 | 544.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|